Copyright
©The Author(s) 2025.
World J Clin Oncol. Sep 24, 2025; 16(9): 108731
Published online Sep 24, 2025. doi: 10.5306/wjco.v16.i9.108731
Published online Sep 24, 2025. doi: 10.5306/wjco.v16.i9.108731
Figure 1 Diagrammatic overview of glioma grades and their key features.
This figure was created by BioRender.com (Supplementary material).
Figure 2 Diagrammatic representation of the biocompatibility concerns associated with mesoporous silica nanoparticles in brain-targeted therapies for glioma, and potential strategies to mitigate their cytotoxicity, including surface PEGylation, targeting of glioma cells, and incorporation of antioxidants.
MSN: Mesoporous silica nanoparticle. This figure was created by BioRender.com (Supplementary material).
Figure 3 Schematic of the internal and external triggers for stimuli-responsive mesoporous silica nanoparticle.
This figure was created by BioRender.com (Supplementary material).
- Citation: Abdel-Maksoud YT, Abdelhaseb AH, Abdo AAE, Kamel AM, Elsebay MT, Attia MS. Responsive mesoporous silica nanocarriers in glioma therapy: A step forward in overcoming biological barriers. World J Clin Oncol 2025; 16(9): 108731
- URL: https://www.wjgnet.com/2218-4333/full/v16/i9/108731.htm
- DOI: https://dx.doi.org/10.5306/wjco.v16.i9.108731